Oruka Therapeutics, Inc. - Common Stock, par value $0.001 per share (ORKA)

Historical Holders from Q3 2024 to Q3 2025

Symbol
ORKA on Nasdaq
CUSIP
687604108
Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
49.6M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
45.6M
Holdings value
$876M
% of all portfolios
0.003%
Grand Portfolio weight change
+0%
Number of holders
101
Number of buys
59
Number of sells
-30
Average Value change %
+0%
Average buys %
+0.001%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Oruka Therapeutics, Inc. - Common Stock, par value $0.001 per share (ORKA)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Fairmount Funds Management LLC 19.99% 0% $162M $38.5M 11.2M +31.1% Fairmount Funds Management LLC Sep 17, 2025
Venrock Healthcare Capital Partners III, L.P. 9.9% -10.9% $94.4M $14.6M 4.91M +18.3% Venrock Healthcare Capital Partners III, L.P. Sep 30, 2025
VIKING GLOBAL INVESTORS LP 5.5% $38.7M 2.67M VIKING GLOBAL INVESTORS LP Sep 17, 2025
BlackRock, Inc. 4.5% -16% $43.4M $4.12M 2.2M +10.5% BlackRock, Inc. Sep 30, 2025
RTW INVESTMENTS, LP 5.2% $18.3M 1.95M RTW Investments, LP Mar 31, 2025
Deep Track Capital, LP 5.07% $17.9M 1.9M Deep Track Capital, LP May 6, 2025

Institutional Holders of Oruka Therapeutics, Inc. - Common Stock, par value $0.001 per share (ORKA)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 45.6M $876M +$221M $19.23 101
2025 Q2 34.4M $386M +$30.4M $11.21 81
2025 Q1 31.8M $326M -$21.5M $10.26 70
2024 Q4 31M $607M +$126M $19.39 66
2024 Q3 24.6M $604M +$604M $24.51 42